ArticleAnnals of surgical oncology2026
Appropriate Proximal Resection Margin Distance for Esophagogastric Junction Adenocarcinoma.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe purpose of this study was to clarify the appropriate proximal resection margin distance for esophagogastric junction (EGJ) adenocarcinoma and evaluate the impact on long-term outcomes. Proximal resection margin and lymph node dissection are critical factors in EGJ adenocarcinoma surgery. However, there is no clear consensus on the appropriate proximal resection margin distance to ensure negative margins, and the prognostic implications are unknown. PATIENTS AND
methodsThis retrospective study included 116 patients with Siewert type II/III EGJ adenocarcinoma who underwent lower esophagectomy with proximal or total gastrectomy. The parameter, delta proximal margin (ΔPM), was used to analyze the discrepancy between gross and pathological proximal margins, while ΔPM' accounted for shrinkage during formalin fixation. Margin recommendations were stratified by cancer stage and histological type, and long-term outcomes were analyzed using survival statistics.
resultsData for 109 patients were analyzed. Recommended gross resection margins ≥ 9 mm were necessary for early stage cancer, ≥ 15 mm for differentiated advanced cancer, and ≥ 21 mm for undifferentiated advanced cancer. Large tumor size (≥ 40 mm) was significantly associated with longer ΔPM' (p = 0.028). In advanced cancers, patients with a gross resection margin < 15 mm had significantly worse relapse-free survival than those with a gross resection margin ≥ 15 mm (p = 0.038). This margin cutoff was a significant prognostic factor in the multivariate analysis (p = 0.017).
conclusionsA gross proximal margin of at least 15 mm appears to reduce positive margins and confer survival advantage for advanced EGJ adenocarcinoma.
Indexed as
Identifiers
41538115What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.